THE BEST SIDE OF HEALTHCARE NEWS

Britain’s drug regulator permitted the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be purchasing it soon after an independent watchdog agency reported the treatment method isn’t worth the Price tag to taxpayersTalking about Demise might be challenging. Here’s how to start out the discussion [deltaMinutes] mins ago Now